Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-047695
Filing Date
2024-11-25
Accepted
2024-11-25 20:30:12
Documents
1
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3123
  Complete submission text file 0001493152-24-047695.txt   4523
Mailing Address 303 N. SWALL DRIVE UNIT #102 BEVERLY HILLS CA 90211
Business Address
Murali Ramachandran (Reporting) CIK: 0001870016 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42275 | Film No.: 241497863

Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Issuer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)